GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Eckert & Ziegler SE (LTS:0NZY) » Definitions » Cyclically Adjusted PS Ratio

Eckert & Ziegler SE (LTS:0NZY) Cyclically Adjusted PS Ratio : 6.21 (As of May. 24, 2025)


View and export this data going back to 2010. Start your Free Trial

What is Eckert & Ziegler SE Cyclically Adjusted PS Ratio?

As of today (2025-05-24), Eckert & Ziegler SE's current share price is €63.20. Eckert & Ziegler SE's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2024 was €10.18. Eckert & Ziegler SE's Cyclically Adjusted PS Ratio for today is 6.21.

The historical rank and industry rank for Eckert & Ziegler SE's Cyclically Adjusted PS Ratio or its related term are showing as below:

LTS:0NZY' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 0.93   Med: 4.3   Max: 16.97
Current: 6.12

During the past years, Eckert & Ziegler SE's highest Cyclically Adjusted PS Ratio was 16.97. The lowest was 0.93. And the median was 4.30.

LTS:0NZY's Cyclically Adjusted PS Ratio is ranked worse than
76.62% of 479 companies
in the Medical Devices & Instruments industry
Industry Median: 2.18 vs LTS:0NZY: 6.12

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Eckert & Ziegler SE's adjusted revenue per share data for the three months ended in Dec. 2024 was €3.819. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is €10.18 for the trailing ten years ended in Dec. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Eckert & Ziegler SE Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Eckert & Ziegler SE's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eckert & Ziegler SE Cyclically Adjusted PS Ratio Chart

Eckert & Ziegler SE Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.81 11.27 4.90 3.99 4.34

Eckert & Ziegler SE Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.99 3.53 4.21 4.04 4.34

Competitive Comparison of Eckert & Ziegler SE's Cyclically Adjusted PS Ratio

For the Medical Devices subindustry, Eckert & Ziegler SE's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Eckert & Ziegler SE's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Eckert & Ziegler SE's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Eckert & Ziegler SE's Cyclically Adjusted PS Ratio falls into.


;
;

Eckert & Ziegler SE Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Eckert & Ziegler SE's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=63.20/10.18
=6.21

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Eckert & Ziegler SE's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2024 is calculated as:

For example, Eckert & Ziegler SE's adjusted Revenue per Share data for the three months ended in Dec. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=3.819/127.0412*127.0412
=3.819

Current CPI (Dec. 2024) = 127.0412.

Eckert & Ziegler SE Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201503 1.602 99.717 2.041
201506 1.654 100.417 2.093
201509 1.592 100.417 2.014
201512 1.763 99.717 2.246
201603 1.693 100.017 2.150
201606 1.186 100.717 1.496
201609 1.351 101.017 1.699
201612 1.437 101.217 1.804
201703 1.551 101.417 1.943
201706 1.514 102.117 1.884
201709 1.683 102.717 2.082
201712 1.806 102.617 2.236
201803 1.690 102.917 2.086
201806 2.158 104.017 2.636
201809 2.107 104.718 2.556
201812 2.217 104.217 2.703
201903 2.127 104.217 2.593
201906 2.206 105.718 2.651
201909 2.144 106.018 2.569
201912 2.201 105.818 2.642
202003 2.160 105.718 2.596
202006 1.901 106.618 2.265
202009 2.102 105.818 2.524
202012 2.366 105.518 2.849
202103 2.145 107.518 2.534
202106 2.193 108.486 2.568
202109 2.000 109.435 2.322
202112 2.357 110.384 2.713
202203 2.398 113.968 2.673
202206 2.759 115.760 3.028
202209 2.803 118.818 2.997
202212 2.721 119.345 2.896
202303 2.778 122.402 2.883
202306 2.878 123.140 2.969
202309 3.160 124.195 3.232
202312 2.989 123.773 3.068
202403 3.244 125.038 3.296
202406 3.729 125.882 3.763
202409 3.362 126.198 3.384
202412 3.819 127.041 3.819

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Eckert & Ziegler SE  (LTS:0NZY) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Eckert & Ziegler SE Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Eckert & Ziegler SE's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Eckert & Ziegler SE Business Description

Traded in Other Exchanges
Address
Robert-Rossle-Street 10, Berlin, BB, DEU, 13125
Eckert & Ziegler SE is a provider of isotope technology for medical, scientific, and industrial use. It is predominantly engaged in the business of cancer therapy, industrial radiometry, and nuclear medical imaging. The company's segments are Medical, Isotope Products, and Other. The Isotope Products segment which generates key revenue, manufactures and distributes standards and radiation sources for medical and industrial purposes. The Medical segment provides pharmaceutical-quality radioactive ingredients and markets products for the treatment and diagnosis of cancers. The Other segment comprises the items of the holding company. Geographically, the company generates a majority of its revenue from Europe and the rest from North America, Asia/Pacific, and other regions.

Eckert & Ziegler SE Headlines

No Headlines